These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3816315)

  • 1. Comparison of 12-hour and 24-hour sustained-release theophylline in outpatient management of asthma.
    Tilles DS; Hales CA
    Chest; 1987 Mar; 91(3):370-5. PubMed ID: 3816315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a new sustained-release theophylline preparation, TheoBeads, with Theo-Dur tablets in children with asthma.
    Welch MJ; Orgel HA; Meltzer EO; Kemp JP; Gawchik S; Rooklin AR; Tinkelman DG
    J Asthma; 1988; 25(5):269-74. PubMed ID: 3182591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
    Ferrari M; Olivieri M; Lampronti G; Bonazza L; Biasin C; Nacci P; Talamini G; Lo Cascio V
    Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily dosing of a new ultrasustained-release theophylline preparation.
    Van den Brande P; Nys J; Tjandramaga TB; Verhelst F; Demedts M
    Respiration; 1987; 52(2):144-53. PubMed ID: 3671893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
    Iwasaki E; Baba M
    Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthma.
    Williams PE; Alwazir YA; Routledge PA; Campbell IA
    Br J Clin Pharmacol; 1986 Oct; 22(4):383-7. PubMed ID: 3768254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a sustained-release preparation (Theo-Dur) with a conventional preparation (Nuelin) in the treatment of chronic asthma.
    Haahtela T; Vilkka V; Kulstad S
    Allergy; 1983 Nov; 38(8):589-92. PubMed ID: 6660438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is a uniform round-the-clock theophylline blood level necessary for optimal asthma therapy in the adolescent patient?
    Bierman CW; Pierson WE; Shapiro GG; Furukawa CT
    Am J Med; 1988 Jul; 85(1B):17-20. PubMed ID: 3041822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomatology in adult asthmatics.
    Arkinstall WW; Atkins ME; Harrison D; Stewart JH
    Am Rev Respir Dis; 1987 Feb; 135(2):316-21. PubMed ID: 3813191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of once-daily Uniphyl tablets compared with twice-daily Theo-Dur tablets in elderly patients with chronic airflow obstruction.
    Rivington RN; Calcutt L; Hodder RV; Stewart JH; Aitken TL
    Am J Med; 1988 Jul; 85(1B):48-53. PubMed ID: 3041826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained-release terbutaline vs sustained-release theophylline in young patients with asthma.
    Roberts JR; Desai HI; Gillespie CA; Simons FE
    Am J Dis Child; 1986 Jul; 140(7):650-4. PubMed ID: 3717101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline absorption from two sustained-release products. Implications for therapeutic drug monitoring.
    Rogers RJ; Wiener MB; Hill MR; Szefler SJ
    Am Rev Respir Dis; 1987 Nov; 136(5):1168-73. PubMed ID: 3674579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline absorption from sustained-release products: comparative steady-state bioavailability of once-daily Theo-Dur, Theo-24, and Uniphyl.
    Hurwitz A; Karim A; Burns TS
    J Clin Pharmacol; 1987 Nov; 27(11):855-61. PubMed ID: 3429692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained-release theophylline for treatment of asthma in preschool children.
    Simons FE; Luciuk GH; Simons KJ
    Am J Dis Child; 1982 Sep; 136(9):790-3. PubMed ID: 7114002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of theophylline chronokinetics for asthmatic children.
    Smolensky MH; Scott PH; McGovern JP
    Prog Clin Biol Res; 1987; 227B():259-70. PubMed ID: 3628336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-a-day dosing with theophylline: a comparison of four sustained-release products.
    Minotti DA; Altman LC; Ayars GH; Popick FR; Benn VJ
    Ann Allergy; 1992 Jun; 68(6):500-6. PubMed ID: 1610026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of once-a-day and twice-a-day theophylline in asthma.
    Fairshter RD; Lowe JE; Wilson AF; Salness K; Novey HS
    Respiration; 1986; 50(3):193-201. PubMed ID: 3797827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state evaluation of two controlled-release theophylline preparations in children.
    Tinkelman DG; Lutz CN; Crummie A; Harrison LI; McCarville SE; Bastyr MH
    J Asthma; 1988; 25(1):27-31. PubMed ID: 3053601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion from twice- to once-daily extended-release theophylline treatment in patients with reversible airway obstruction.
    Berkowitz RB; Tinkelman DG; Marcoux JP; Rooklin AR; Zeitz HJ; Rennard SI; Moss BA; Hubbard RC; Lorber RR
    J Asthma; 1995; 32(4):275-84. PubMed ID: 7629003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.